We are in the dawn of a new age in diabetes management.

PEOPLE WITH DIABETES CAN…

exercise without worry

HEALTHCARE PROVIDERS CAN…

make more informed decisions

Scroll to find out how

clinical trial hours since 2008

 
30 Patents
12 Clinical
Sites
30 Clinical
Trials
450 Patients
inControl Diabetes Management Platform

TypeZero is leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.

Our Products

People with Diabetes

Effectively managing your diabetes is a daily struggle, and you need a solution that’s safe, simple, and effective. TypeZero’s inControl platform includes advisory applications for smart insulin pens and smartphone-based artificial pancreas systems that automatically regulate insulin delivery, drastically reduce hypoglycemia, and significantly improve blood glucose levels. inControl eliminates the need for minute-to-minute decision making, allowing you to spend less time managing your diabetes and more time living your life. inControl also reduces the significant device burden many persons with diabetes face by offering a streamlined system that can be tailored to fit your unique needs and lifestyle.

People with Diabetes

Healthcare Professionals

TypeZero’s therapy optimization tools can help you guide your patients to make smarter decisions about their diabetes management. Whether it’s adjusting basal regimens, tweaking carb ratios, or coaching patients on when and what to eat, TypeZero’s clinician-oriented products give you data-driven insight into a patient’s habits, areas of risk, and opportunities for parameter changes. Drawing on next-generation data science techniques, proven metabolic models, and a deep understanding of the challenges facing providers today, TypeZero’s therapy optimization suite includes data aggregation, risk analysis, and data visualization tools.

Healthcare Professionals

Our Team

We're a diverse team of passionate, seasoned professionals with significant experience in diabetes research, medical devices, software development, and start-up management. Our team is dedicated to changing the way the world treats and manages diabetes.

Meet the Team
  • Chad Rogers

    CEO
  • Patrick Keith-Hynes

    CSO
  • Colin Steele

    CTO
  • Daniel Cherñavvsky

    CMO
  • Meagan Collins

    Operations Manager
  • Jon Dale

    UI/UX Designer & Software Engineer
  • Ryan DeRose

    VP of Product Development
  • Joe Lawson

    Director of Developer Operations
  • Molly McElwee-Malloy

    Head of Patient Engagement
  • Benton Mize

    Software Engineer
  • Stephen Patek

    VP of Research and Development
  • James Quinn

    VP of Engineering
  • Antoine Robert

    Software Engineer
  • Brandon Rose

    Quality System Management Director
  • Boris Kovatchev

    Chief Mathemetician
  • Marc Breton

    Algorithm Researcher
Show More

Chad Rogers

CEO

Chad is a founder and the CEO of TypeZero. He is focused on the day-to-day strategy, operations, product vision and overall commercialization efforts for the company. Chad comes from a start-up background in medical devices and software.

Patrick Keith-Hynes

CSO

As a TypeZero founder and Chief Science Officer, Patrick is focused on rapidly bringing the inControl system to market. Patrick developed the DiAs smartphone-based Artificial Pancreas system as an assistant research professor at the University of Virginia.

Colin Steele

CTO

Colin brings more than 20 years of diverse experience in IT, consulting, and start-up management to TypeZero. As Chief Technology Officer, Colin drives the implementation of all technical architecture and software development for TypeZero's diabetes products and solutions.

Daniel Cherñavvsky

CMO

Danny is TypeZero’s Chief Medical Officer. As a pediatric nephrologist who works extensively with children with type 1 and type 2 diabetes, Danny ensures TypeZero’s products and company strategy meet the diverse needs of the diabetes community.

Meagan Collins

Operations Manager

Meagan oversees TypeZero’s day-to-day office operations and provides project management and communications support. Her background is in corporate communications and medical education administration.

Jon Dale

UI/UX Designer & Software Engineer

Jon is TypeZero’s lead UI/UX designer and a software engineer. Jon brings an expertise in front end development and user-centric design.

Ryan DeRose

VP of Product Development

Ryan leads TypeZero’s product development efforts. Founder of a local digital creative agency, Ryan brings an expertise in digital marketing, creative strategy and design.

Joe Lawson

Director of Developer Operations

Joe brings more than 15 years of software development and engineering experience to TypeZero. As senior director of Developer Operations, Joe oversees cloud infrastructure development, deployment practices, and information security and compliance for the company.

Molly McElwee-Malloy

Head of Patient Engagement

Molly is Head of Patient Engagement and Director of Marketing at TypeZero. She is focused on ensuring the patient is at the epicenter of TypeZero’s mission, as well as supporting the company’s quality management initiatives. Molly has had T1D since 1998.

Benton Mize

Software Engineer

Benton, T1D since 2005, has worked on the inControl platform from its early development at UVA to the current sophisticated version at TypeZero. He is passionate about device integration and communication, as well as reducing system complexity for fellow persons with diabetes.

Stephen Patek

VP of Research and Development

Steve is a founder of TypeZero and serves as VP of Research and Development. He is responsible for generating and evaluating new algorithm concepts for advanced treatments of diabetes. Steve splits his time between TypeZero and the University of Virginia where he is an Associate Professor of Systems and Information Engineering and has been involved in diabetes technology research since 2007.

James Quinn

VP of Engineering

As TypeZero’s director of software engineering, James leads the company’s technology adoption and product testability and execution efforts. He employs big data processes, statistical analysis, and behavior modeling to advance TypeZero’s software solutions.

Antoine Robert

Software Engineer

Antoine has been involved with the development of the Artificial Pancreas platform since 2012. At TypeZero, he is focused on the design and development of mobile applications and cloud-oriented solutions to support diabetes management.

Brandon Rose

Quality System Management Director

Brandon manages TypeZero’s software processes to ensure compliance with FDA and ISO requirements, as well as oversees the implementation of all quality management system documentation and procedures. He brings more than 15 years of engineering, regulatory, and quality management experience to the company.

Boris Kovatchev

Chief Mathemetician

Boris is a founder and Chief Mathematician at TypeZero. He is the founder of UVA’s Center for Diabetes Technology and has spent the past 20 years of his career advancing the field of diabetes management through the invention of new models, algorithms and new closed loop technologies.

Marc Breton

Algorithm Researcher

Marc, a TypeZero founder, is a faculty member of UVA’s School of Medicine and School of Engineering. Co-founder of the UVA Artificial Pancreas Team (2006), Marc focuses on insulin dosing solutions and computer simulations for therapy optimization in diabetes.

In the News

Stay informed on the latest news. We've compiled stories, press releases, blogs and news about TypeZero and the diabetes community to keep you up-to-date on relevant happenings in the industry.

TypeZero in the Press

Read more Read more

From TypeZero

Insights on today's challenges, opportunities, and interesting facts – directly from our team.

Meagan Collins

Meagan Collins

Why Your Spreadsheets Suck
Read more
Read more

Our Partners